CN103293307B - Satb2蛋白作为结肠直肠癌标记的应用 - Google Patents

Satb2蛋白作为结肠直肠癌标记的应用 Download PDF

Info

Publication number
CN103293307B
CN103293307B CN201310187869.7A CN201310187869A CN103293307B CN 103293307 B CN103293307 B CN 103293307B CN 201310187869 A CN201310187869 A CN 201310187869A CN 103293307 B CN103293307 B CN 103293307B
Authority
CN
China
Prior art keywords
satb2
protein
cancer
colorectal cancer
expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201310187869.7A
Other languages
English (en)
Chinese (zh)
Other versions
CN103293307A (zh
Inventor
M·乌莱恩
F·庞蒂恩
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Atlas Antibodies AB
Original Assignee
Atlas Antibodies AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Atlas Antibodies AB filed Critical Atlas Antibodies AB
Publication of CN103293307A publication Critical patent/CN103293307A/zh
Application granted granted Critical
Publication of CN103293307B publication Critical patent/CN103293307B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G01N33/57535—
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57419—Specifically defined cancers of colon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4703—Regulators; Modulating activity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN201310187869.7A 2006-06-02 2007-06-04 Satb2蛋白作为结肠直肠癌标记的应用 Active CN103293307B (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP06114954.8 2006-06-02
EP06114954A EP1862803A1 (en) 2006-06-02 2006-06-02 Use of protein SATB2 as a marker for colorectal cancer
US81661306P 2006-06-27 2006-06-27
US60/816,613 2006-06-27
CNA2007800204929A CN101460850A (zh) 2006-06-02 2007-06-04 Satb2蛋白作为结肠直肠癌标记的应用

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CNA2007800204929A Division CN101460850A (zh) 2006-06-02 2007-06-04 Satb2蛋白作为结肠直肠癌标记的应用

Publications (2)

Publication Number Publication Date
CN103293307A CN103293307A (zh) 2013-09-11
CN103293307B true CN103293307B (zh) 2016-03-23

Family

ID=36968849

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201310187869.7A Active CN103293307B (zh) 2006-06-02 2007-06-04 Satb2蛋白作为结肠直肠癌标记的应用
CNA2007800204929A Pending CN101460850A (zh) 2006-06-02 2007-06-04 Satb2蛋白作为结肠直肠癌标记的应用

Family Applications After (1)

Application Number Title Priority Date Filing Date
CNA2007800204929A Pending CN101460850A (zh) 2006-06-02 2007-06-04 Satb2蛋白作为结肠直肠癌标记的应用

Country Status (11)

Country Link
US (3) US8067190B2 (enExample)
EP (3) EP1862803A1 (enExample)
JP (2) JP4990970B2 (enExample)
CN (2) CN103293307B (enExample)
AT (2) ATE513216T1 (enExample)
AU (1) AU2007256391B2 (enExample)
CA (1) CA2653952A1 (enExample)
DK (2) DK2211180T3 (enExample)
ES (1) ES2367412T3 (enExample)
PL (1) PL2211180T3 (enExample)
WO (1) WO2007140966A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100662821B1 (ko) * 2006-04-05 2006-12-28 유니트마 주식회사 레시피언트 블록 성형용 몰드 및 이를 이용한 레시피언트블록의 제조방법
EP1862803A1 (en) 2006-06-02 2007-12-05 Atlas Antibodies AB Use of protein SATB2 as a marker for colorectal cancer
EP2107375A1 (en) * 2008-03-31 2009-10-07 Atlas Antibodies AB Uses of WARS protein in cancer prognostics
EP2172477A1 (en) 2008-10-06 2010-04-07 Atlas Antibodies AB Epitopes derived from SATB2 and uses thereof
US8632984B2 (en) * 2009-02-16 2014-01-21 Atlas Antibodies Ab RBM3 as a marker for malignant melanoma prognosis
ES2709056T3 (es) * 2014-05-13 2019-04-15 Vastcon La sobreexpresión de la metionina aminopeptidasa en la sangre periférica y las células mononucleares de la sangre periférica son un marcador para la detección, el diagnóstico y el pronóstico del cáncer colorrectal
CA2975223C (en) * 2015-01-30 2021-08-24 Glax Llc Compositions and methods for monitoring, diagnosis, prognosis, detection, and treatment of cancer
US20160258438A1 (en) * 2015-03-05 2016-09-08 Regal Beloit America, Inc. Assembly, blower and associated method
WO2016176446A2 (en) * 2015-04-29 2016-11-03 Geneoscopy, Llc Colorectal cancer screening method and device
US11479820B2 (en) 2016-10-27 2022-10-25 Geneoscopy, Inc. Detection method using eukaryotic cells
CN106841131A (zh) * 2016-12-29 2017-06-13 上海交通大学 一种基于角蛋白自荧光作为预测检测肿瘤的生物标志物的检测方法及其应用
EP3802885A4 (en) 2018-06-01 2022-03-02 Geneoscopy, LLC DETECTION PROCEDURE
EP3833779A4 (en) * 2018-08-08 2022-05-11 Indian Institute Of Science Education And Research COMBINED EXPRESSION PATTERN OF SATB FAMILY CHROMATIN ORGANIZERS AS AN IMPROVED BIOMARKER TOOL FOR CANCER PREDICTION
US12435335B2 (en) 2022-06-06 2025-10-07 Cornell University Promoting nutrient absorption through the colon

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9828840D0 (en) 1998-12-30 1999-02-17 Univ Nottingham Trent Prostate cancer associated genes and their products
DE19932688B4 (de) 1999-07-13 2009-10-08 Scil Proteins Gmbh Design von Beta-Faltblatt-Proteinen des gamma-II-kristallins antikörperähnlichen
WO2003022126A2 (en) * 2001-08-21 2003-03-20 Corixa Corporation Compositions and methods for the therapy and diagnosis of colon cancer
US20090215711A1 (en) * 2004-04-30 2009-08-27 Sagres Discovery, Inc. Novel compositions and methods in cancer
DE102004037860A1 (de) 2004-08-04 2006-03-16 Friedrich-Alexander-Universität Erlangen-Nürnberg Turmormarker zur Diagnose von Karzinomen und/oder davon abstammender Metastasen
CN102191320A (zh) * 2005-05-02 2011-09-21 东丽株式会社 用于诊断食管癌的组合物及方法
GB2435882A (en) 2006-03-09 2007-09-12 Bioinvent Int Ab Detection and treatment of mantle cell lymphoma
EP1862803A1 (en) 2006-06-02 2007-12-05 Atlas Antibodies AB Use of protein SATB2 as a marker for colorectal cancer

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Biology of Colorectal Liver Metastases:A Review;Nigel C.Bird et al.;《Journal of Surgical Oncology》;20060731;第94卷(第1期);第68页第2栏、第96页第27-29行 *
Molecular markers in prognosis of colorectal cancer and prediction of response to treatment;PASCHE B ET AL;《BEST PRACTICE & RESEARCH. CLINICAL GASTROENTEROLOGY》;20020430;第16卷(第2期);第331-345页 *

Also Published As

Publication number Publication date
JP2012073260A (ja) 2012-04-12
US8465934B2 (en) 2013-06-18
ES2367412T3 (es) 2011-11-03
EP2024747A1 (en) 2009-02-18
US20120270956A1 (en) 2012-10-25
WO2007140966A1 (en) 2007-12-13
PL2211180T3 (pl) 2011-11-30
DK2211180T3 (da) 2011-09-26
ATE513216T1 (de) 2011-07-15
JP2009539082A (ja) 2009-11-12
JP4990970B2 (ja) 2012-08-01
US8241859B2 (en) 2012-08-14
AU2007256391B2 (en) 2011-05-19
CA2653952A1 (en) 2007-12-13
CN103293307A (zh) 2013-09-11
JP5301630B2 (ja) 2013-09-25
DK2024747T3 (da) 2011-09-19
CN101460850A (zh) 2009-06-17
EP1862803A1 (en) 2007-12-05
US20090220975A1 (en) 2009-09-03
US20120028836A1 (en) 2012-02-02
EP2024747B1 (en) 2011-06-15
EP2211180A1 (en) 2010-07-28
EP2211180B1 (en) 2011-06-22
US8067190B2 (en) 2011-11-29
AU2007256391A1 (en) 2007-12-13
ATE514090T1 (de) 2011-07-15

Similar Documents

Publication Publication Date Title
CN103293307B (zh) Satb2蛋白作为结肠直肠癌标记的应用
JP5689133B2 (ja) 結腸直腸癌におけるｐｏｄｘｌタンパク質
AU2009339802B2 (en) RBM3 as a marker for malignant melanoma prognosis
JP2012501440A (ja) 内分泌処置予測因子としてのａｎｌｎタンパク質
EP2107375A1 (en) Uses of WARS protein in cancer prognostics
EP2390665A1 (en) Prostate cancer biomarkers
CN102171241A (zh) 从satb2衍生的表位及其用途
EP2055717A1 (en) Prognostic method
EP2241889A1 (en) RBM3 protein in colorectal cancer prognostics

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant